Discovery May Lead to Improvements in Treating Alzheimer's Disease
the Psychiatry Advisor take:
A new drug target to fight Alzheimer's disease might also be used as a diagnostic tool for the disease, according to researchers at Pennsylvania State University.
A team found that the GABA neurotransmitter was drastically increased in the deformed versions of the normally large, star-shaped "astrocyte" cells which,support individual neurons in the brain. High concentrations of that neurotransmitter is a novel biomarker that researchers hope can be further investigated a a diagnosis tool and for treatment.
Research behind many drugs in development for Alzheimer's targets the sticky buildup of the amyloid protein known as plaques, which can cause neurons in the brain to die.
Japanese Drugmaker Accelerates Development of Alzheimer's Drug
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Methylphenidate for ADHD Treatment May Be Associated With Low BMI
- Patients With Schizophrenia May Benefit From Occupational Therapy
- Minocycline vs Routine Care for Clinical Symptom Improvement in Schizophrenia
- Temperament Traits May Predict Treatment Outcomes Depression
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Psychotic Experiences Linked to Anxiety and Somatic Symptoms in Preadolescent
- DSM-5 Anxious Distress Specifier Valid for Major Depressive Disorder
- Social Stigma Worsens Mental Health With Autism
- Onset of Psychosis Not Related to Cognitive Deterioration in Schizophrenia